US President Donald Trump is considering significant tariffs, potentially 200% on pharmaceuticals and 50% on copper imports, expanding his trade policies. These measures aim to boost US revenue. India is assessing the impact, with concerns about disrupted exports. US President Donald Trump is considering significant tariffs, potentially 200% on pharmaceuticals and 50% on copper imports, expanding his trade policies. These measures aim to boost US revenue. India is assessing the impact, with concerns about disrupted exports.
